{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T20:37:01Z","timestamp":1784147821252,"version":"3.55.0"},"reference-count":38,"publisher":"AVES YAYINCILIK A.\u015e.","issue":"6","license":[{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T00:00:00Z","timestamp":1500422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AOTT"],"abstract":"<jats:p>Abstract\n\n\nThe aim of this study was to determine factors associated with the likelihood of a better clinical outcome after the peritendinous injection of PRP for the treatment of chronic tendinopathy and identify whether PRP represents an effective treatment option for chronic tendinopathies. The study included 214 patients (86 males and 128 females; mean age: 39.3 (18\u201375) years) who received PRP injections for tendinopathy refractory to conventional treatments. The mean duration of symptoms at the moment of the PRP treatment was 8.3 months. Primary outcome measurement was perceived improvement in symptoms for each anatomic compartment for upper and lower limbs at 6 months after treatment. Also, a visual analog scale (VAS) score (pain intensity on a 0\u201310 scale) was used for pain scoring questionnaire before treatment, 6 weeks and 6 months following the PRP injection(s). To identify factors associated with the likelihood of a better clinical outcome, patients were categorized on the basis of their perceived improvement in symptoms 6 months after the PRP injection(s)\u2014that is, as lower (less than 50% global improvement) or higher (more than 50% global improvement). A visual analogue scale score and perceived improvement in symptoms were significantly lower after peritendinous injection in 6-week and 6-month follow-ups compared with the baseline (P &lt; 0.001) except for peroneal and Achilles tendons. Overall, 83% of patients indicated moderate to complete improvement in symptoms. The most common injection sites were the lateral epicondyle, Achilles, and patellar tendons. Furthermore, 30% of patients received only 1 injection, 30% received 2 injections, and 40% received 3 or more injections. A total of 85% of patients were satisfied (more than 50% global improvement) with the procedure. In addition, upper limb tendons, increase in the age, and female gender were associated with a higher likelihood of perceived improvement in symptoms. In the present retrospective study assessing PRP injections in the treatment of chronic tendinopathy, a moderate improvement (&gt;50%) in pain symptoms was observed in most of the patients. Our research found that results were most promising with patellar and lateral epicondylar tendinopathy in the short to medium term. Female patients, patients with upper extremity tendinopathy and older patients appeared to benefit more from PRP injection. Level IV, Therapeutic study.\nER -\n\n \n\nKeywords\n\n \n\n\n\tPlatelet-rich plasma\n\tTendinopathy\n\tInjection\n\tAchilles tendon\n\tPatellar tendon\n\tLateral epicondylitis<\/jats:p>","DOI":"10.1016\/j.aott.2017.10.003","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T22:15:37Z","timestamp":1509747337000},"page":"482-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Peritendinous injection of platelet-rich plasma to treat tendinopathy: A retrospective review"],"prefix":"10.5152","volume":"51","author":[{"given":"Mehmet","family":"Can UNLU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aybars","family":"K\u0130VRAK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Enes KAYAALP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olgar","family":"B\u0130RSEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Is\u0131k","family":"AKGUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3111","published-online":{"date-parts":[[2020,2,6]]},"reference":[{"issue":"2","key":"10.1016\/j.aott.2017.10.003_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.fcl.2005.01.013","article-title":"Achilles tendon disorders: etiology and epidemiology","volume":"10","author":"J\u00e4rvinen","year":"2005","journal-title":"Foot Ankle Clin"},{"issue":"4","key":"10.1016\/j.aott.2017.10.003_bib2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0278-5919(03)00004-8","article-title":"Types and epidemiology of tendinopathy","volume":"22","author":"Maffulli","year":"2003","journal-title":"Clin Sports Med"},{"issue":"4","key":"10.1016\/j.aott.2017.10.003_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/jor.21009","article-title":"Ibuprofen upregulates expressions of matrix metalloproteinase-1, -8, -9, and -13 without affecting expressions of types I and III collagen in tendon cells","volume":"28","author":"Tsai","year":"2010","journal-title":"J\u00a0Orthop Res"},{"issue":"9754","key":"10.1016\/j.aott.2017.10.003_bib4","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(10)61160-9","article-title":"Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomized controlled trials","volume":"376","author":"Coombes","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.aott.2017.10.003_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00007256-200939050-00002","article-title":"Platelet rich therapies in the treatment of orthopaedic sport injuries","volume":"39","author":"Sanchez","year":"2009","journal-title":"Sports Med"},{"issue":"6","key":"10.1016\/j.aott.2017.10.003_bib6","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00264-009-0845-7","article-title":"Use of platelet-rich plasma for the treatment of refractory jumper's knee","volume":"34","author":"Filardo","year":"2010","journal-title":"Int Orthop"},{"issue":"6","key":"10.1016\/j.aott.2017.10.003_bib7","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/0363546508330974","article-title":"Use of autologous platelet-rich plasma to treat muscle strain injuries","volume":"37","author":"Hammond","year":"2009","journal-title":"Am J Sports Med"},{"issue":"2","key":"10.1016\/j.aott.2017.10.003_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/0363546509355445","article-title":"Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up","volume":"38","author":"Peerbooms","year":"2010","journal-title":"Am J Sports Med"},{"issue":"10","key":"10.1016\/j.aott.2017.10.003_bib9","doi-asserted-by":"crossref","first-page":"602","DOI":"10.5435\/00124635-200910000-00002","article-title":"Platelet-rich plasma: current concepts and application in sports medicine","volume":"17","author":"Hall","year":"2009","journal-title":"J\u00a0Am Acad Orthop Surg"},{"issue":"1","key":"10.1016\/j.aott.2017.10.003_bib10","first-page":"187","article-title":"Tendon injury and tendinopathy: healing and repair","volume":"87","author":"Sharma","year":"2005","journal-title":"J\u00a0Bone Jt Surg Am"},{"issue":"2","key":"10.1016\/j.aott.2017.10.003_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jama.2009.1986","article-title":"Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial","volume":"303","author":"de Vos","year":"2010","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.aott.2017.10.003_bib12","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1177\/0363546510397173","article-title":"Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up","volume":"39","author":"Gosens","year":"2011","journal-title":"Am J Sports Med"},{"issue":"2","key":"10.1016\/j.aott.2017.10.003_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0363546506294078","article-title":"Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices","volume":"35","author":"Sanchez","year":"2007","journal-title":"Am J Sports Med"},{"issue":"2","key":"10.1016\/j.aott.2017.10.003_bib14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/036354659502300215","article-title":"Resection and repair for medial tennis elbow. A prospective analysis","volume":"23","author":"Ollivierre","year":"1995","journal-title":"Am J Sports Med"},{"issue":"5","key":"10.1016\/j.aott.2017.10.003_bib15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jvir.2014.01.026","article-title":"Intratendinous injection of platelet-rich plasma under US guidance to treat tendinopathy: a long-term pilot study","volume":"25","author":"Dallaudi\u00e8re","year":"2014","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"3","key":"10.1016\/j.aott.2017.10.003_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pmrj.2012.12.010","article-title":"Outcomes after ultrasound-guided platelet-rich plasma injections for chronic tendinopathy: a multicenter, retrospective review","volume":"5","author":"Mautner","year":"2013","journal-title":"PMR"},{"issue":"3","key":"10.1016\/j.aott.2017.10.003_bib17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/0363546512472975","article-title":"Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial","volume":"41","author":"Krogh","year":"2013","journal-title":"Am J Sports Med"},{"issue":"2","key":"10.1016\/j.aott.2017.10.003_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejr.2011.12.001","article-title":"Local injection of autologous platelet rich plasma and corticosteroid in treatment of lateral epicondylitis and plantar fasciitis: randomized clinical trial","volume":"34","author":"Omar Aziza","year":"2012","journal-title":"Egypt Rheumatol"},{"issue":"2","key":"10.1016\/j.aott.2017.10.003_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/0269215512448388","article-title":"Comparison of the therapeutic effects of ultrasound-guided platelet-rich plasma injection and dry needling in rotator cuff disease: a randomized controlled trial","volume":"27","author":"Rha","year":"2013","journal-title":"Clin Rehabil"},{"issue":"11","key":"10.1016\/j.aott.2017.10.003_bib20","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1177\/0363546513496542","article-title":"Platelet-rich plasma injections in the treatment of chronic rotator cuff tendinopathy: a randomized controlled trial with 1-year follow-up","volume":"41","author":"Kesikburun","year":"2013","journal-title":"Am J Sports Med"},{"issue":"1\u20132","key":"10.1016\/j.aott.2017.10.003_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/ten.tea.2013.0197","article-title":"Multipotent mesenchymal stem cells from human subacromial bursa: potential for cell based tendon tissue engineering","volume":"20","author":"Song","year":"2014","journal-title":"Tissue Eng Part A"},{"issue":"2","key":"10.1016\/j.aott.2017.10.003_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jse.2012.02.007","article-title":"Bone marrow- derived cells from the footprint infiltrate into the repaired rotator cuff","volume":"22","author":"Kida","year":"2013","journal-title":"J\u00a0Shoulder Elb Surg"},{"issue":"3","key":"10.1016\/j.aott.2017.10.003_bib23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1177\/0363546512473269","article-title":"Isolation and characterization of human mesenchymal stem cells derived from shoulder tissues involved in rotator cuff tears","volume":"41","author":"Utsunomiya","year":"2013","journal-title":"Am J Sports Med"},{"issue":"5","key":"10.1016\/j.aott.2017.10.003_bib24","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.arthro.2013.01.019","article-title":"Efficacy of marrow-stimulating technique in arthroscopic rotator cuff repair: a prospective randomized study","volume":"29","author":"Milano","year":"2013","journal-title":"Arthroscopy"},{"issue":"5","key":"10.1016\/j.aott.2017.10.003_bib25","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.arthro.2011.09.016","article-title":"Repeated platelet concentrate injections enhance reparative response of microfractures in the treatment of chondral defects of the knee: an experimental study in an animal model","volume":"28","author":"Milano","year":"2012","journal-title":"Arthroscopy"},{"issue":"3","key":"10.1016\/j.aott.2017.10.003_bib26","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/0363546513518416","article-title":"Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomized controlled trial","volume":"42","author":"Dragoo","year":"2014","journal-title":"Am J Sports Med"},{"issue":"4","key":"10.1016\/j.aott.2017.10.003_bib27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1177\/0363546513475345","article-title":"Platelet-rich plasma versus focused shock waves in the treatment of jumper's knee in athletes","volume":"41","author":"Vetrano","year":"2013","journal-title":"Am J Sports Med"},{"issue":"6","key":"10.1016\/j.aott.2017.10.003_bib28","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.injury.2008.11.026","article-title":"Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper's knee","volume":"40","author":"Kon","year":"2009","journal-title":"Injury"},{"issue":"1","key":"10.1016\/j.aott.2017.10.003_bib29","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.3928\/01477447-20121217-20","article-title":"Platelet-rich plasma as an effective treatment for proximal hamstring injuries","volume":"36","author":"Wetzel","year":"2013","journal-title":"Orthopedics"},{"issue":"10","key":"10.1016\/j.aott.2017.10.003_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1302\/2046-3758.210.2000200","article-title":"Achilles tendinopathy management: a pilot randomised controlled trial comparing platelet-rich plasma injection with an eccentric loading programme","volume":"2","author":"Kearney","year":"2013","journal-title":"Bone Jt Res"},{"issue":"4","key":"10.1016\/j.aott.2017.10.003_bib31","first-page":"595","article-title":"Treatment of chronic patellar tendinosis with buffered platelet rich plasma: a preliminary study","volume":"60","author":"Volpi","year":"2007","journal-title":"Med Sport"},{"issue":"6","key":"10.1016\/j.aott.2017.10.003_bib32","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.jfas.2012.06.009","article-title":"A\u00a0prospective series of patients with chronic Achilles tendinopathy treated with autologous-conditioned plasma injections combined with exercise and therapeutic ultrasonography","volume":"51","author":"Deans","year":"2012","journal-title":"J\u00a0Foot Ankle Surg"},{"issue":"5","key":"10.1016\/j.aott.2017.10.003_bib33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/1071100713475353","article-title":"Injectable treatments for noninsertional Achilles tendinosis: a systematic review","volume":"34","author":"Gross","year":"2013","journal-title":"Foot Ankle Int"},{"issue":"19","key":"10.1016\/j.aott.2017.10.003_bib34","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.L.00019","article-title":"Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy","volume":"94","author":"McCarrel","year":"2012","journal-title":"J\u00a0Bone Jt Surg Am"},{"issue":"1","key":"10.1016\/j.aott.2017.10.003_bib35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/0363546513507566","article-title":"Increasing platelet concentrations in leukocyte-reduced platelet-rich plasma decrease collagen gene synthesis in tendons","volume":"42","author":"Boswell","year":"2014","journal-title":"Am J Sports Med"},{"issue":"1","key":"10.1016\/j.aott.2017.10.003_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3928\/01477447-20121217-06","article-title":"Biologically enhanced healing of the human rotator cuff: 8-month postoperative histological evaluation","volume":"36","author":"Protzman","year":"2013","journal-title":"Orthopedics"},{"issue":"2","key":"10.1016\/j.aott.2017.10.003_bib37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/JSM.0b013e31829aa410","article-title":"Exuberant inflammatory reaction as a side effect of platelet-rich plasma injection in treating one case of tendinopathy","volume":"24","author":"Kaux","year":"2014","journal-title":"Clin J Sport Med"},{"issue":"9","key":"10.1016\/j.aott.2017.10.003_bib38","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00167-013-2549-1","article-title":"Progression of patellar tendinitis following treatment with platelet-rich plasma: case reports","volume":"21","author":"Bowman","year":"2013","journal-title":"Knee Surg Sports Traumatol Arthrosc"}],"container-title":["Acta Orthopaedica et Traumatologica Turcica"],"original-title":[],"link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1017995X17304169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1017995X17304169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aott.org.tr\/index.php\/pub\/article\/download\/3312\/3259","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:45:33Z","timestamp":1763466333000},"score":1,"resource":{"primary":{"URL":"https:\/\/aott.org.tr\/index.php\/pub\/article\/view\/3312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,6]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,1,6]]}},"URL":"https:\/\/doi.org\/10.1016\/j.aott.2017.10.003","relation":{},"ISSN":["2589-1294","1017-995X"],"issn-type":[{"value":"2589-1294","type":"electronic"},{"value":"1017-995X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peritendinous injection of platelet-rich plasma to treat tendinopathy: A retrospective review","name":"articletitle","label":"Article Title"},{"value":"Acta Orthopaedica et Traumatologica Turcica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aott.2017.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Turkish Association of Orthopaedics and Traumatology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}